vs
勃肯（BIRK）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是勃肯的1.2倍（$622.0M vs $526.3M），Royalty Pharma plc净利率更高（34.4% vs 19.3%，领先15.2%），过去两年勃肯的营收复合增速更高（26.8% vs 4.6%）
勃肯是源自德国的知名鞋履制造商，1774年成立，总部位于莱茵兰-普法尔茨州维德河畔诺伊施塔特。品牌标志性产品采用麂皮、黄麻层叠打造的弧形软木鞋垫，可贴合穿着者脚型，尤以舒适凉鞋品类闻名，创立初衷是为替代当时普遍的平底鞋，推出兼具支撑性与贴合度的鞋款。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
BIRK vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$526.3M
净利率更高
RPRX
高出15.2%
19.3%
两年增速更快
BIRK
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $526.3M | $622.0M |
| 净利润 | $101.4M | $214.2M |
| 毛利率 | 62.8% | — |
| 营业利润率 | 23.0% | 62.4% |
| 净利率 | 19.3% | 34.4% |
| 营收同比 | — | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIRKRPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | $526.3M | $609.3M | ||
| Q2 25 | $685.8M | $578.7M | ||
| Q1 25 | $620.3M | $568.2M | ||
| Q4 24 | $390.7M | $593.6M | ||
| Q3 24 | $455.8M | $564.7M | ||
| Q2 24 | $609.9M | $537.3M | ||
| Q1 24 | $519.7M | $568.0M |
净利润BIRKRPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | $101.4M | $288.2M | ||
| Q2 25 | $139.6M | $30.2M | ||
| Q1 25 | $113.5M | $238.3M | ||
| Q4 24 | $21.7M | $208.2M | ||
| Q3 24 | — | $544.0M | ||
| Q2 24 | $80.6M | $102.0M | ||
| Q1 24 | $77.4M | $4.8M |
毛利率BIRKRPRX
| Q4 25 | — | — | ||
| Q3 25 | 62.8% | — | ||
| Q2 25 | 60.5% | — | ||
| Q1 25 | 57.7% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 59.5% | — | ||
| Q1 24 | 56.3% | — |
营业利润率BIRKRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | 23.0% | 70.1% | ||
| Q2 25 | 31.2% | 36.3% | ||
| Q1 25 | 30.5% | 94.0% | ||
| Q4 24 | 17.7% | 60.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | 27.5% | 50.2% | ||
| Q1 24 | 27.5% | -13.0% |
净利率BIRKRPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | 19.3% | 47.3% | ||
| Q2 25 | 20.3% | 5.2% | ||
| Q1 25 | 18.3% | 41.9% | ||
| Q4 24 | 5.6% | 35.1% | ||
| Q3 24 | — | 96.3% | ||
| Q2 24 | 13.2% | 19.0% | ||
| Q1 24 | 14.9% | 0.8% |
每股收益（稀释后）BIRKRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $355.4M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.9B | $9.7B |
| 总资产 | $5.3B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资BIRKRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $355.4M | $938.9M | ||
| Q2 25 | $282.8M | $631.9M | ||
| Q1 25 | $254.2M | $1.1B | ||
| Q4 24 | $322.5M | $929.0M | ||
| Q3 24 | $384.3M | $950.1M | ||
| Q2 24 | $436.7M | $1.8B | ||
| Q1 24 | $189.8M | $843.0M |
总债务BIRKRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益BIRKRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | $2.9B | $9.6B | ||
| Q2 25 | $2.8B | $9.5B | ||
| Q1 25 | $3.0B | $9.8B | ||
| Q4 24 | $3.0B | $10.3B | ||
| Q3 24 | $2.8B | $10.3B | ||
| Q2 24 | $2.8B | $9.8B | ||
| Q1 24 | $2.7B | $9.9B |
总资产BIRKRPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | $5.3B | $19.3B | ||
| Q2 25 | $5.3B | $18.3B | ||
| Q1 25 | $5.4B | $17.6B | ||
| Q4 24 | $5.4B | $18.2B | ||
| Q3 24 | $5.3B | $18.0B | ||
| Q2 24 | $5.4B | $17.7B | ||
| Q1 24 | $5.2B | $16.1B |
负债/权益比BIRKRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $415.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 4.09× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BIRKRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $415.0M | $702.6M | ||
| Q2 25 | — | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | $-12.6M | $742.5M | ||
| Q3 24 | $463.0M | $703.6M | ||
| Q2 24 | — | $658.2M | ||
| Q1 24 | — | $664.6M |
现金转化率BIRKRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 4.09× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | -0.58× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIRK
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
